Omeprazole; Sodium Bicarbonate Patent Expiration
Omeprazole; Sodium Bicarbonate is Used for reducing the risk of upper gastrointestinal bleeding and short-term treatment of active benign gastric ulcers in critically ill patients. It was first introduced by Salix Pharmaceuticals Inc
Omeprazole; Sodium Bicarbonate Patents
Given below is the list of patents protecting Omeprazole; Sodium Bicarbonate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Konvomep | US11771686 | Compositions and kits for omeprazole suspension | Mar 01, 2040 | Azurity |
| Konvomep | US10751333 | Compositions and kits for omeprazole suspension | Jul 16, 2039 | Azurity |
| Konvomep | US11103492 | Compositions and kits for omeprazole suspension | Jul 16, 2039 | Azurity |
| Konvomep | US11633478 | Compositions and kits for Omeprazole suspension | Jul 16, 2039 | Azurity |
| Konvomep | US11911473 | Compositions and kits for omeprazole suspension | Jul 16, 2039 | Azurity |
| Konvomep | US12042539 | Compositions and kits for Omeprazole suspension | Jul 16, 2039 | Azurity |
| Konvomep | US12329752 | Compositions and kits for omeprazole suspension | Jul 16, 2039 | Azurity |
| Zegerid | US5840737 | Omeprazole solution and method for using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | US6489346 | Substituted benzimidazole dosage forms and method of using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | US6645988 | Substituted benzimidazole dosage forms and method of using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | US6699885 | Substituted benzimidazole dosage forms and methods of using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | US6780882 | Substituted benzimidazole dosage forms and method of using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | US7399772 | Substituted benzimidazole dosage forms and method of using same |
Jul 16, 2016
(Expired) | Salix |
| Zegerid | USRE45198 | Omeprazole solution and method for using same |
Jul 15, 2016
(Expired) | Salix |
| Zegerid Otc | US5840737 | Omeprazole solution and method for using same |
Jul 15, 2016
(Expired) | Riley Consumer |
| Zegerid Otc | US6489346 | Substituted benzimidazole dosage forms and method of using same |
Jul 15, 2016
(Expired) | Riley Consumer |
| Zegerid Otc | US6645988 | Substituted benzimidazole dosage forms and method of using same |
Jul 15, 2016
(Expired) | Riley Consumer |
| Zegerid Otc | US6699885 | Substituted benzimidazole dosage forms and methods of using same |
Jul 15, 2016
(Expired) | Riley Consumer |
| Zegerid Otc | US6780882 | Substituted benzimidazole dosage forms and method of using same |
Jul 15, 2016
(Expired) | Riley Consumer |
| Zegerid Otc | US7399772 | Substituted benzimidazole dosage forms and method of using same |
Jul 15, 2016
(Expired) | Riley Consumer |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Omeprazole; Sodium Bicarbonate's patents.
Latest Legal Activities on Omeprazole; Sodium Bicarbonate's Patents
Given below is the list recent legal activities going on the following patents of Omeprazole; Sodium Bicarbonate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Correspondence Address Change Critical
| 03 Nov, 2005 | US6780882 |
| Correspondence Address Change Critical
| 28 Oct, 2005 | US6780882 |
| File Marked Found | 23 Mar, 2005 | US6780882 |
| Correspondence Address Change Critical
| 11 Mar, 2005 | US6780882 |
| File Marked Lost | 04 Mar, 2005 | US6780882 |
| Correspondence Address Change Critical
| 11 Nov, 2004 | US6780882 |
| Correspondence Address Change Critical
| 27 Oct, 2004 | US6780882 |
| Patent Issue Date Used in PTA Calculation Critical
| 24 Aug, 2004 | US6780882 |
| Recordation of Patent Grant Mailed Critical
| 24 Aug, 2004 | US6780882 |
| Issue Notification Mailed Critical
| 05 Aug, 2004 | US6780882 |
Omeprazole; Sodium Bicarbonate's Family Patents
